Certified Drug Label Translations in 26 Languages for Limited English Proficient Patients with Sharon Blank RxTran TRANSCRIPT
Download PDFAug 17, 2026
Sharon Blank, CEO of RxTran, highlights the value of certified translations of prescription dosing instructions in 26 languages to ensure that limited-English-proficient patients can understand dosing and medication risks. The organization works with pharmacies to deliver translations created by native-speaking...
Aug 17, 2026
Sharon Blank, CEO of RxTran, highlights the value of certified translations of prescription dosing instructions in 26 languages to ensure that limited-English-proficient patients can understand dosing and medication risks. The organization works with pharmacies to deliver translations created by native-speaking...
Jul 6, 2026
Richard Garr, CEO and General Counsel of Curative Biotechnology, discusses the company's work in repurposing the diabetes drug metformin into an eye drop for degenerative eye diseases. The goal of the therapy is retinal preservation, aiming to slow or stop disease progression by acting at the cellular level in the back...
How Pharmacogenomics Testing Reduces Polypharmacy Risks with Dr. Houda Hachad Aranscia TRANSCRIPT
Download PDFJun 23, 2026
Dr. Houda Hachad, Vice President of Clinical Operations at Aranscia, highlights the importance of regular medication reviews in an age of growing polypharmacy and advancements in the use of pharmacogenomics to identify potential risks. The key goal is to use the minimal effective dose of a medication and determine...
Jun 23, 2026
Dr. Houda Hachad, Vice President of Clinical Operations at Aranscia, highlights the importance of regular medication reviews in an age of growing polypharmacy and advancements in the use of pharmacogenomics to identify potential risks. The key goal is to use the minimal effective dose of a medication and determine...